{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:01:17Z","timestamp":1780290077804,"version":"3.54.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pediatric thyroid nodules have higher malignancy rates than adult nodules, necessitating accurate diagnostic evaluation. This study evaluated the correlation between fine needle aspiration (FNA) results using the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) and postoperative histopathological findings in pediatric patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective analysis included 696 pediatric patients who underwent ultrasound-guided FNA for thyroid nodules from 2017-2024. Cytological results were classified according to TBSRTC 2023 criteria and correlated with histopathological outcomes in 246 surgically resected cases. Molecular testing included\n                      <jats:italic>BRAF<\/jats:italic>\n                      V600E mutation analysis on FNA specimens in non-operated patients, while\n                      <jats:italic>TERT<\/jats:italic>\n                      promoter mutations,\n                      <jats:italic>RAS<\/jats:italic>\n                      mutations, and\n                      <jats:italic>RET<\/jats:italic>\n                      fusions were assessed in formalin-fixed paraffin-embedded surgical specimens. Risk of malignancy (ROM) was calculated using conservative (ROM-C) and histological (ROM-H) approaches. Diagnostic performance was assessed for definitive cytological categories (II, IV, V, and VI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 246 operated patients, the overall ROM ranged from 32.76% (ROM-C) to 92.68% (ROM-H). ROM increased progressively across Bethesda categories: II (1.11%-27.27%), III (25.40%-66.67%), IV (22.22%-100%), V (74.70%-100%), and VI (82.39%-100%). Papillary thyroid carcinoma predominated (88.62%).\n                      <jats:italic>BRAF<\/jats:italic>\n                      V600E mutation was detected in 51.53% of histologically confirmed malignancies and 10.96% in FNA samples from patients who did not undergo surgery.\n                      <jats:italic>RET<\/jats:italic>\n                      gene fusions were identified in 5.24% of malignant cases,\n                      <jats:italic>TERT<\/jats:italic>\n                      promoter mutations in 0.44%, while no\n                      <jats:italic>RAS<\/jats:italic>\n                      mutations were detected. Within definitive cytological categories (II, IV, V, and VI), the Bethesda system demonstrated sensitivity of 98.58%, specificity of 100%, and accuracy of 98.63%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The Bethesda system provides high diagnostic accuracy for definitive cytological categories in pediatric thyroid nodules. Even indeterminate categories carry elevated malignancy risk, supporting careful surgical consideration and the value of\n                      <jats:italic>BRAF<\/jats:italic>\n                      V600E testing for preoperative risk stratification.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1750424","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:19:16Z","timestamp":1780287556000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The correlation between fine needle aspiration diagnosis and postoperative histopathological results of pediatric thyroid nodules based on the Bethesda system"],"prefix":"10.3389","volume":"17","author":[{"given":"Xue","family":"Bai","sequence":"first","affiliation":[{"name":"Department of Pathology, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pathology, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Pathology, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1530\/ey.15.3.12","article-title":"Thyroid nodules in pediatric patients: Sonographic characteristics and likelihood of cancer","volume":"288","author":"Richman","year":"2018","journal-title":"Radiology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf090","article-title":"Approach to the pediatric patient with thyroid nodules","volume":"110","author":"Lai","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.16257","article-title":"Thyroid nodules in children and adolescents: Investigation and management","volume":"58","author":"Sandy","year":"2022","journal-title":"J Paediatrics Child Health"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/ey.20.1.13","article-title":"2022 European Thyroid Association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma","volume":"11","author":"Lebbink","year":"2022","journal-title":"Eur Thyroid J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2016.0353","article-title":"Fine needle aspiration in the investigation of thyroid nodules","volume":"113","author":"Feldkamp","year":"2016","journal-title":"Deutsches Arzteblatt Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2023.05.005","article-title":"The 2023 bethesda system for reporting thyroid cytopathology","volume":"33","author":"Ali","year":"2023","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaf034","article-title":"Pediatric thyroid nodules: A comprehensive study of cytology, histology, molecular findings, and risk of Malignancy with emphasis on atypia of undetermined significance category","volume":"164","author":"Ixchel Sanchez","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22831","article-title":"Malignant risk of pediatric Bethesda category III thyroid nodules subcategorized by nuclear atypia and other: A single institution experience","volume":"132","author":"Jin","year":"2024","journal-title":"Cancer Cytopathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2020.2020.0213","article-title":"Evaluation of children and adolescents with thyroid nodules: A single center experience","volume":"13","author":"Elmao\u011fullar\u0131","year":"2021","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02441-y","article-title":"2020 Chinese guidelines for ultrasound Malignancy risk stratification of thyroid nodules: The C-TIRADS","volume":"70","author":"Zhou","year":"2020","journal-title":"Endocrine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0728","article-title":"Differences in thyroid nodule cytology and Malignancy risk between children and adults","volume":"29","author":"Cherella","year":"2019","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153975","article-title":"Performance of ACR TI-RADS and the Bethesda System in predicting risk of Malignancy in thyroid nodules at a large children\u2019s hospital and a comprehensive review of the pediatric literature","volume":"15","author":"Hess","year":"2023","journal-title":"Cancers"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0317","article-title":"Malignancy rate in thyroid nodules classified as Bethesda category III (AUS\/FLUS)","volume":"24","author":"Ho","year":"2014","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14176112","article-title":"Toward standardized management of indeterminate thyroid nodules in pediatric patients: A systematic review and call for a comprehensive risk stratification model","volume":"14","author":"Tuli","year":"2025","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0702","article-title":"The use of the Bethesda System for Reporting Thyroid Cytopathology in pediatric thyroid nodules: A meta-analysis","volume":"31","author":"Vuong","year":"2021","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.3390\/diagnostics12010179","article-title":"Performance of the Bethesda System for Reporting Thyroid Cytology in multi-institutional large cohort of pediatric thyroid nodules: A detailed analysis","volume":"12","author":"Canberk","year":"2022","journal-title":"Diagnostics (Basel Switzerland)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/ey.20.1.5","article-title":"Evaluation of the molecular landscape of pediatric thyroid nodules and use of a multigene genomic classifier in children","volume":"8","author":"Gallant","year":"2022","journal-title":"JAMA Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/ey.19.3.14","article-title":"Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers","volume":"40","author":"Franco","year":"2022","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2021-0741","article-title":"Genomic landscape of sporadic pediatric differentiated thyroid cancers: A systematic review and meta-analysis","volume":"35","author":"Satapathy","year":"2022","journal-title":"J Pediatr Endocrinol Metabolism: JPEM"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2024.162126","article-title":"The Bethesda System for Reporting Thyroid Cytopathology: Risk of Malignancy in pediatric thyroid nodules","volume":"60","author":"Pintos","year":"2025","journal-title":"J Pediatr Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2025.08.005","article-title":"An updated review on the use of fine needle aspiration biopsy in pediatric thyroid disease","volume":"31","author":"Aekka","year":"2025","journal-title":"Endocrine Practice: Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf110","article-title":"Multiplatform molecular testing as an adjunct to fine needle aspiration in the evaluation of pediatric thyroid nodules","volume":"110","author":"Aekka","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.70013","article-title":"Recent advances in diagnostics and therapeutics for paediatric thyroid cancer","volume":"61","author":"Vanderniet","year":"2025","journal-title":"J Paediatrics Child Health"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2009.07.022","article-title":"Pediatric thyroid fine-needle aspiration cytology: A meta-analysis","volume":"44","author":"Stevens","year":"2009","journal-title":"J Pediatr Surg"},{"key":"B27","article-title":"Thyroid nodules in childhood: A single institute experience","volume":"20","author":"Mirshemirani","year":"2010","journal-title":"Iranian J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2015.09.189","article-title":"Histologic and clinical follow-up of thyroid fine-needle aspirates in pediatric patients","volume":"124","author":"Partyka","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12674","DOI":"10.1038\/s41598-022-16207-1","article-title":"The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/ijgm.s327409","article-title":"Gene mutation analysis in papillary thyroid carcinoma using a multi-gene panel in China","volume":"14","author":"Wang","year":"2021","journal-title":"Int J Gen Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12022-025-09859-y","article-title":"Prevalence and clinical impact of BRAF p.V600E mutation in papillary thyroid carcinoma","volume":"36","author":"Brumfield","year":"2025","journal-title":"Endocr Pathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24935","article-title":"BRAF V600E mutational status in pediatric thyroid cancer","volume":"61","author":"Henke","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1530\/erc-23-0117","article-title":"RET fusion genes in pediatric and adult thyroid carcinomas: Cohort characteristics and prognosis","volume":"30","author":"Bulanova Pekova","year":"2023","journal-title":"Endocrine-Related Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1530\/ey.19.3.13","article-title":"NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","volume":"131","author":"Lee","year":"2021","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-99-6782-7_1","article-title":"Addressing the impact of international variation in thyroid cytology: Which reporting system is best for patients","volume-title":"Thyroid FNA cytology: differential diagnoses and pitfalls","author":"Kakudo","year":"2023"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1481804","article-title":"Ultrasound and histopathological assessment of benign, borderline, and Malignant thyroid tumors in pediatric patients: An illustrative review and literature overview","volume":"15","author":"Janu\u015b","year":"2024","journal-title":"Front Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-023-09764-2","article-title":"Thyroid nodules and follicular cell-derived thyroid carcinomas in children","volume":"34","author":"Slack","year":"2023","journal-title":"Endocr Pathol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1750424\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:19:17Z","timestamp":1780287557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1750424\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":37,"alternative-id":["10.3389\/fendo.2026.1750424"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1750424","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"article-number":"1750424"}}